Home Cart 0 Sign in  

[ CAS No. 146256-97-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 146256-97-5
Chemical Structure| 146256-97-5
Structure of 146256-97-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 146256-97-5 ]

Related Doc. of [ 146256-97-5 ]

Alternatived Products of [ 146256-97-5 ]

Product Details of [ 146256-97-5 ]

CAS No. :146256-97-5 MDL No. :MFCD15142792
Formula : C14H25NO6 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 303.35 Pubchem ID :-
Synonyms :

Safety of [ 146256-97-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 146256-97-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 146256-97-5 ]
  • Downstream synthetic route of [ 146256-97-5 ]

[ 146256-97-5 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 146256-97-5 ]
  • [ 146256-98-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4399 - 4403
[2] Patent: US2016/75708, 2016, A1, . Location in patent: Paragraph 0104; 0106
[3] Patent: KR2015/139962, 2015, A, . Location in patent: Paragraph 0155; 0158; 0161-0162
  • 2
  • [ 146256-97-5 ]
  • [ 146256-98-6 ]
  • [ 170123-25-8 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1993, # 12, p. 1313 - 1318
  • 3
  • [ 146256-97-5 ]
  • [ 170123-25-8 ]
YieldReaction ConditionsOperation in experiment
41% With potassium <i>tert</i>-butylate In toluene at -10 - 0℃; for 1.5 h; Inert atmosphere To a suspension of potassium tert-butoxide (791 mg, 7.05 mmol) in anhydrous toluene (19 mL) at 10 C a solution of 30 (1.43 g, 4.7 mmol) in toluenewas added dropwise. The reactionwas stirred at 0 C for 90 min and then it was quenched with acetic acid (500 mL), followed by the addition of a cold solution of NaH2-PO4USDH2O (2.5 g) in 25 mL of water. The layers were separated, and the aqueous phase was extracted with CHCl3. The combined organic layers were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude product was purified by flash chromatography (silica gel, pet. ether/EtOAc 5:1, Rf 0.44) obtaining the title compound 31 as a yellow oil (497 mg, 41percent yield). 1H NMR (CDCl3, 200 MHz) major rotamer: d 4.55 and 4.47 (s, 1H), 4.27-4.22 (m, 2H), 3.91-3.84 (m) and 3.82 (t, J = 8.2 Hz) 2H, 2.69 (t, J = 8.0 Hz, 2H), 1.49 and 1.43 (s, 9H), 1.30 (t, J = 7.1 Hz, 3H). Anal. C12H19NO5 (C, H, N).
Reference: [1] Chemical Communications, 2016, vol. 52, # 53, p. 8271 - 8274
[2] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 15, p. 2179 - 2187
[3] Organic Letters, 2007, vol. 9, # 21, p. 4255 - 4258
[4] Tetrahedron Asymmetry, 2005, vol. 16, # 13, p. 2243 - 2247
[5] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 6, p. 1931 - 1938
[6] European Journal of Medicinal Chemistry, 2012, vol. 56, p. 96 - 107
[7] Journal of the American Chemical Society, 2003, vol. 125, # 40, p. 12172 - 12178
  • 4
  • [ 146256-97-5 ]
  • [ 146256-98-6 ]
  • [ 170123-25-8 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1993, # 12, p. 1313 - 1318
  • 5
  • [ 146256-97-5 ]
  • [ 101385-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4399 - 4403
Same Skeleton Products
Historical Records